Brand Name : Asofix-CV
Packing : 10*6
Composition : Cefixime 200mg +Potassium Clavulanate 125mg Tablet
Composition : Cefixime 200mg +Potassium Clavulanate 125mg Tablet
Antibiotic resistance is a growing concern in the medical field, making it essential to choose treatment options that are not only effective but also designed to combat stubborn and resistant bacterial strains. Asofix-CV, an innovative formulation from Norchem Healthcare, is crafted with precision to meet this challenge. This combination of Cefixime and Clavulanic Acid is widely used for treating a range of infections that do not respond well to standard antibiotics.
Asofix-CV Tablet
Norchem Healthcare – A trusted name in the Indian pharmaceutical industry known for its quality, innovation, and commitment to patient care.
This combination is available in tablet and dry syrup forms, making it suitable for both adults and pediatric patients.
Cefixime is a third-generation cephalosporin antibiotic. It exhibits strong bactericidal action against a wide range of Gram-positive and Gram-negative bacteria. It acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death.
Clavulanic Acid is a β-lactamase inhibitor, which doesn’t possess significant antibacterial activity itself, but it prevents the destruction of Cefixime by β-lactamase enzymes produced by resistant bacteria. This ensures the effectiveness of Cefixime against otherwise resistant strains.
The synergy between Cefixime and Clavulanic Acid allows Asofix-CV to be highly effective in cases where regular cephalosporins fail. Clavulanic Acid inactivates the β-lactamase enzymes produced by resistant bacteria, allowing Cefixime to reach its target and destroy the bacteria. This makes Asofix-CV an ideal choice in treating infections caused by β-lactamase-producing pathogens.
Asofix-CV is used to treat a wide range of infections caused by susceptible organisms, including:
Especially where resistance to conventional antibiotics is suspected.
Important: Complete the full course even if symptoms improve to prevent bacterial resistance.
Asofix-CV is generally well tolerated. However, some patients may experience mild to moderate side effects:
Rare but serious side effects:
Note: If any serious side effects occur, discontinue use and consult a doctor immediately.
Healthcare professionals across India prefer Asofix-CV for its:
It has emerged as a first-line treatment in many outpatient and hospital-based infection protocols.
Norchem Healthcare invites passionate distributors and entrepreneurs to become part of its growing network through its PCD Pharma Franchise model. With a growing demand for effective antibiotics like Asofix-CV, franchise partners can benefit immensely from this product's popularity and trust.
Whether you're new to pharma or looking to expand your portfolio, Asofix-CV offers strong market potential.
In an age of growing antibiotic resistance, healthcare providers need reliable, effective, and evidence-based solutions. Asofix-CV from Norchem Healthcare is one such advanced antibiotic combination that delivers on all fronts—efficacy, safety, and affordability. Its widespread utility in respiratory, urinary, and gastrointestinal infections, along with its action against resistant strains, makes it a must-have in every medical prescription pad.
For franchise partners, Asofix-CV offers not just a product, but a profitable business opportunity backed by one of India’s most reputed pharmaceutical companies. With strong branding, quality assurance, and marketing support from Norchem Healthcare, your journey into the pharma business is in the right hands.